Expression of CK7, Cam 5.2 and Ber-Ep4 in cutaneous squamous cell carcinoma

Loren E. Clarke, Andrea B. Conway, Nicole M. Warner, Patricia N. Barnwell, Jennifer Sceppa, Klaus Helm

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Background Cytokeratin 7 (CK7) and Cam 5.2 are often used to differentiate extramammary Paget's disease (EPD) from squamous cell carcinoma (SCC) in situ because they are generally considered to be expressed in the former but not in the latter. However, we have encountered CK7+ and Cam 5.2+ SCCs. Methods We evaluated CK7, Cam 5.2 and Ber-Ep4 expression in SCC and EPD. Results We found significant CK7 and Cam 5.2 positivity in SCCs, particularly in those with a pagetoid pattern. Only one case expressed Ber-Ep4. Conclusions We conclude that CK7 and Cam 5.2 expression may occur in SCC. A panel including Ber-Ep4 is advisable for immunohistochemical differentiation of EPD from SCC.

Original languageEnglish (US)
Pages (from-to)646-650
Number of pages5
JournalJournal of Cutaneous Pathology
Volume40
Issue number7
DOIs
Publication statusPublished - Jul 1 2013

    Fingerprint

Cite this

Clarke, L. E., Conway, A. B., Warner, N. M., Barnwell, P. N., Sceppa, J., & Helm, K. (2013). Expression of CK7, Cam 5.2 and Ber-Ep4 in cutaneous squamous cell carcinoma. Journal of Cutaneous Pathology, 40(7), 646-650. https://doi.org/10.1111/cup.12135